
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
DIH Holdings US, Inc. Class A Common Stock (DHAI)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: DHAI (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -14.9% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.88M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.03 | 52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.79% | Operating Margin (TTM) -17.49% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26684334 | Price to Sales(TTM) 0.17 |
Enterprise Value 26684334 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 47336300 | Shares Floating 15773934 |
Shares Outstanding 47336300 | Shares Floating 15773934 | ||
Percent Insiders 50.42 | Percent Institutions 12.13 |
Upturn AI SWOT
DIH Holdings US, Inc. Class A Common Stock
Company Overview
History and Background
DIH Holdings US, Inc. is a global med-tech company that provides solutions for rehabilitation and human performance. It was established through the integration of various companies with expertise in robotics, virtual reality, and sensor technology, aiming to create a comprehensive rehabilitation ecosystem.
Core Business Areas
- Rehabilitation Robotics: Develops and markets robotic devices for upper and lower extremity rehabilitation, targeting stroke, spinal cord injury, and other neurological conditions.
- Virtual Reality Rehabilitation: Offers VR-based rehabilitation platforms for immersive therapy and motor skills training.
- Human Performance Solutions: Provides tools and technologies for assessing and improving human performance in sports, healthcare, and industrial settings.
Leadership and Structure
DIH Holdings US, Inc. is led by a management team with experience in medical technology, robotics, and healthcare. The organizational structure is designed to support its global operations and innovation efforts.
Top Products and Market Share
Key Offerings
- Andago: A robotic gait trainer for rehabilitation, allowing patients to practice walking in a safe and controlled environment. Competitors include Hocoma (Lokomat) and ReWalk Robotics. Market share data is not publicly available but Andago is a leading product within DIH's robotics segment which makes up 45% of its revenue
- Diego: A robotic arm rehabilitation device that helps patients regain upper extremity function. Competitors include Kinova and MyoPro. Market share data is not publicly available but Diego is a leading product within DIH's robotics segment which makes up 45% of its revenue
- Tyromotion AMADEO: A hand rehabilitation device that helps patients regain upper extremity function. Competitors include SaeboFlex and Interactive Metronome. Market share data is not publicly available but Amadeo is a leading product within DIH's robotics segment which makes up 45% of its revenue
Market Dynamics
Industry Overview
The rehabilitation technology market is growing due to an aging population, increasing prevalence of neurological disorders, and rising demand for advanced rehabilitation solutions. The industry is characterized by innovation in robotics, VR/AR, and sensor technologies.
Positioning
DIH Holdings US, Inc. is positioned as a comprehensive rehabilitation solutions provider, offering a range of products and technologies across different rehabilitation modalities. Its competitive advantages include its integrated product portfolio and global reach.
Total Addressable Market (TAM)
The global rehabilitation robotics market is projected to reach several billion USD in the coming years. DIH Holdings US, Inc. is positioned to capture a significant portion of this TAM by offering innovative products and solutions across the rehabilitation continuum.
Upturn SWOT Analysis
Strengths
- Comprehensive product portfolio
- Global presence
- Technological innovation
- Established brand reputation
Weaknesses
- Limited profitability
- High R&D expenses
- Competition from larger players
- Dependence on healthcare reimbursement policies
Opportunities
- Expanding into new markets
- Developing new products and services
- Forming strategic partnerships
- Leveraging telemedicine and remote monitoring
Threats
- Technological obsolescence
- Changing reimbursement policies
- Economic downturns
- Increased competition
Competitors and Market Share
Key Competitors
- Hocoma (Switzerland)
- ReWalk Robotics (RWLK)
- Ekso Bionics (EKSO)
Competitive Landscape
DIH Holdings US, Inc. competes with other rehabilitation technology companies based on product innovation, clinical efficacy, and market reach. Its comprehensive product portfolio and global presence are key competitive advantages. However, competition is strong from larger, well-established players.
Major Acquisitions
Motek Medical
- Year: 2018
- Acquisition Price (USD millions): 80
- Strategic Rationale: Expanded DIH's virtual reality-based rehabilitation solutions.
Hocoma
- Year: 2019
- Acquisition Price (USD millions): 85
- Strategic Rationale: Hocoma acquisition strengthened the company's robotics business.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be accurately assessed due to limited publicly available financial data.
Future Projections: Future growth projections are not readily available without specific analyst forecasts.
Recent Initiatives: Recent initiatives may include new product launches, partnerships with healthcare providers, and expansions into new geographic markets. This information is specific to the parent company.
Summary
DIH Holdings US, Inc. is a significant player in the rehabilitation technology market with a comprehensive portfolio and global reach. While they have a strong product base and innovation, profitability and competition from larger companies pose challenges. Their future success depends on their ability to capitalize on growth opportunities and navigate a competitive landscape.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Analyst Reports (Limited Availability)
Disclaimers:
This analysis is based on limited publicly available information and analyst estimates. Financial data and market share information may not be precise and should be considered approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DIH Holdings US, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Norwell, MA, United States | ||
IPO Launch date 2022-03-21 | Founder, Chairman & CEO Mr. Jason Chen | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.dih.com |
Full time employees - | Website https://www.dih.com |
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.